Uhlmann Price Securities LLC Invests $629,000 in Ventas, Inc. $VTR

Uhlmann Price Securities LLC bought a new stake in Ventas, Inc. (NYSE:VTR) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 7,659 shares of the real estate investment trust’s stock, valued at approximately $629,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of VTR. GoalVest Advisory LLC purchased a new position in Ventas during the 4th quarter worth $26,000. Wiser Advisor Group LLC acquired a new position in Ventas in the third quarter valued at $27,000. IFC & Insurance Marketing Inc. purchased a new stake in shares of Ventas in the fourth quarter valued at about $30,000. Elyxium Wealth LLC purchased a new stake in shares of Ventas in the fourth quarter valued at about $33,000. Finally, Reflection Asset Management acquired a new stake in shares of Ventas during the fourth quarter worth about $34,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Insiders Place Their Bets

In other Ventas news, Director Michael J. Embler bought 2,500 shares of Ventas stock in a transaction on Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director owned 28,349 shares in the company, valued at $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by company insiders.

Ventas Stock Performance

NYSE VTR opened at $81.61 on Friday. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The business’s 50 day moving average is $85.07 and its two-hundred day moving average is $82.58. Ventas, Inc. has a 12-month low of $61.76 and a 12-month high of $91.06. The stock has a market capitalization of $39.68 billion, a price-to-earnings ratio of 148.38, a PEG ratio of 1.75 and a beta of 0.71.

Ventas (NYSE:VTR) last posted its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the business earned $0.84 earnings per share. The firm’s quarterly revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Research analysts expect that Ventas, Inc. will post 3.88 EPS for the current year.

Ventas Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be given a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.5%. Ventas’s dividend payout ratio is presently 378.18%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on VTR. Mizuho set a $98.00 price target on Ventas in a report on Friday, May 22nd. Scotiabank reduced their price objective on Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a research note on Thursday. Wells Fargo & Company increased their price objective on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Raymond James Financial initiated coverage on Ventas in a research report on Tuesday. They set an “outperform” rating and a $94.00 price objective for the company. Finally, UBS Group lifted their target price on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research note on Monday, May 4th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $96.00.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.